Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TEACH: Azithromycin and Tobramycin in Cystic Fibrosis
NCT02677701Phase 4Completed
- Sponsor
- Seattle Children's
- Start
- Oct 2016
- Primary completion
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in cystic fibrosis (CF) comparing Azithromycin with Placebo (2 arms). Primary endpoint: Relative Change in Lung Function (FEV1) at 6 weeks. Started Oct 2016; status: completed.
02
Drugs
azithromycin
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT02677701.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02677701.